Raritan, N.J. – October 5, 2010 — iContracts, a leading provider of solutions for managing corporate contracts, commitments, and compliance today announced that Cornerstone Therapeutics Inc.®, a pharmaceutical company specializing in the respiratory and related markets, has expanded their scope of solutions from iContracts™ to manage chargebacks, rebates, Medicaid, and government pricing compliance by licensing iContracts Dashboard/Reporting. iContracts Dashboard and Reporting module provides a company with reporting and analytical capabilities across all aspects of the contract and compliance lifecycle. This includes financial analysis, contract performance and “what if” analysis. The dashboard also provides a method to report on current operational benchmarks and review historical trends.
Donna Forbes White, Director of Commercial and Business Analytics, with Cornerstone Therapeutics, commented “iContracts has provided us with functional and practical solutions for management of chargebacks, rebates, Medicaid and government pricing. Now, through the addition of the Dashboard and Reporting modules, we will be able to monitor contract performance and compliance in a more efficient manner. Additionally, these modules will allow us to perform additional financial analysis and provide reports that include graphs and charts to our management team. With iContracts quick implementation time, we will even be able to utilize the advanced capabilities of these modules in our 2011 budget planning process.”
“iContracts fully integrated suite of solutions for pharmaceutical manufacturers includes an optimized, pre-defined data store that eliminates the need for our clients to embark on costly and time/resource consuming projects to build and access critical information”, observed Todd Venetianer, Chief Operating Officer of iContracts. “We are gratified to have a fast-growing public company like Cornerstone as a client, and proud that they have further expanded an already strong relationship by licensing our powerful solution for reporting and analysis.”
iContracts solutions are available as an “on demand” service or as a behind-the-firewall offering and are built on iContracts’ revolutionary BCS platform featuring an advanced data architecture, rich functionality and Simplified Common User Interface (SCUI) enabling users to execute any process after learning just two basic screen formats. This groundbreaking design drastically reduces implementation, training and future upgrade timeframes and costs.
About iContracts
iContracts’ goal is simple – to deliver better solutions for managing contracts that are faster, easier and less expensive to implement. This mantra is reflected in everything we do. Our software is generations ahead of other solutions, powered by a Simplified Common User Interface (SCUI) that makes every user an “expert” by learning just two simple, reusable views and backed by the most highly evolved data architecture in the industry – built by technologists with considerable and unique experience in building contract management solutions for the Life Sciences industry. This deep understanding and straightforward approach shows in everything we do. iContracts comprehensive suite of solutions manages all aspects of a Life Science company’s chargeback, rebate and Medicaid processes as well as other incentive agreements and Government Pricing compliance at all levels. Our solutions are enterprise-class and can be quickly and easily integrated with any off-the-shelf or custom system to meet exacting business requirements without the army of consultants and endless fees associated with other products and providers. For more information, please visit www.icontracts.com.
About Cornerstone Therapeutics Inc.
Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets. The Company currently promotes multiple marketed products in the United States to respiratory-focused physicians and key retail pharmacies with its specialty sales force. The Company also has a late-stage clinical pipeline with a recent regulatory submission filing and four additional regulatory approval submissions targeted within the next three years. Key elements of the Company’s strategy are to in-license or acquire rights to underpromoted, patent-protected, branded respiratory or related pharmaceutical products or late-stage product candidates; implement life cycle management strategies to maximize the potential value and competitive position of the Company’s currently marketed products, newly acquired products and product candidates that are currently in development; grow product revenue through the Company’s specialty sales force, which is focused on the respiratory and related markets; and maintain and strengthen the intellectual property position of the Company’s currently marketed products, newly acquired products and product candidates.
iContracts Media Contact:
Anne Ambrosio
iContracts, Inc.
Tel: 908-393-9550
aambrosio@icontracts.com